What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Analgesic
R Andrew Moore mainly investigates Anesthesia, Placebo, Analgesic, Adverse effect and Neuropathic pain.
Many of his studies involve connections with topics such as Number needed to treat and Anesthesia.
His studies in Placebo integrate themes in fields like Morphine, Cochrane Library and Migraine.
His biological study spans a wide range of topics, including Clinical study design, Clinical trial, Acetaminophen, Cancer pain and Saline.
His Adverse effect research integrates issues from Ketamine, Surgery and Incidence.
His Neuropathic pain study also includes
- Gabapentin that connect with fields like Pregabalin and Anticonvulsant,
- Chronic pain which connect with Meta-analysis, Pain assessment and Trigeminal neuralgia.
His most cited work include:
- The visual analogue pain intensity scale: what is moderate pain in millimetres? (1111 citations)
- Opioids in chronic non-cancer pain: systematic review of efficacy and safety (958 citations)
- Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review (453 citations)
What are the main themes of his work throughout his whole career to date?
R Andrew Moore spends much of his time researching Placebo, Anesthesia, Adverse effect, Analgesic and Number needed to treat.
His studies deal with areas such as Meta-analysis, Internal medicine, Clinical trial and Physical therapy, Chronic pain as well as Placebo.
His work carried out in the field of Anesthesia brings together such families of science as Ibuprofen and Tolerability.
His Adverse effect research incorporates elements of Osteoarthritis, Surgery and Relative risk, Cochrane Library, Confidence interval.
His research investigates the connection between Analgesic and topics such as Neuropathic pain that intersect with issues in Gabapentin, Pregabalin and Trigeminal neuralgia.
His Number needed to treat research includes elements of Ketoprofen, Aspirin, Headaches, Oxycodone and Migraine.
He most often published in these fields:
- Placebo (53.79%)
- Anesthesia (51.89%)
- Adverse effect (40.91%)
What were the highlights of his more recent work (between 2015-2021)?
- Placebo (53.79%)
- Anesthesia (51.89%)
- Analgesic (38.26%)
In recent papers he was focusing on the following fields of study:
R Andrew Moore mainly focuses on Placebo, Anesthesia, Analgesic, Clinical trial and Number needed to treat.
R Andrew Moore combines subjects such as Tolerability, Adverse effect, Internal medicine, Fibromyalgia and Chronic pain with his study of Placebo.
His Anesthesia study integrates concerns from other disciplines, such as Oxycodone and Cancer pain, Pain ladder.
The study incorporates disciplines such as Hydromorphone and Neuropathic pain in addition to Analgesic.
His research integrates issues of Meta-analysis, Physical therapy and Osteoarthritis in his study of Clinical trial.
His Number needed to treat research is multidisciplinary, incorporating perspectives in Pain assessment, Gabapentin, Clinical study design, Publication bias and Postherpetic neuralgia.
Between 2015 and 2021, his most popular works were:
- Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. (343 citations)
- Topical NSAIDS for chronic musculoskeletal pain in adults (201 citations)
- Oral morphine for cancer pain (176 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
